Audit 47261

FY End
2022-03-31
Total Expended
$4.21M
Findings
4
Programs
3
Organization: Chicot Memorial Medical Center (AR)
Year: 2022 Accepted: 2023-01-02
Auditor: Eide Bailly LLP

Organization Exclusion Status:

Checking exclusion status...

Findings

ID Ref Severity Repeat Requirement
42634 2022-005 Material Weakness - ABL
42635 2022-006 Material Weakness - ABL
619076 2022-005 Material Weakness - ABL
619077 2022-006 Material Weakness - ABL

Contacts

Name Title Type
DJ82XLSGA958 Tim Hall Auditee
6013261000 Tyler Bernier Auditor
No contacts on file

Notes to SEFA

Title: Basis of Presentation Accounting Policies: Expenditures reported on the schedule are reported on the accrual basis of accounting, with the exception for the COVID19 Claims Reimbursement for the Uninsured Program and the COVID19 Coverage Assistance Fund (Federal Financial Assistance Listing / CFDA #93.461), which is based on when the claim is eligible evidenced by the receipt of monies from the federal agency. When applicable, such expenditures are recognized following the cost principles contained in the Uniform Guidance, wherein certain types of expenditures are not allowable or are limited as to reimbursement. No federal financial assistance has been provided to a subrecipient. De Minimis Rate Used: N Rate Explanation: The Medical Center has not elected to use the 10% de minimis cost rate. The accompanying schedule of expenditures of federal awards (the schedule) includes the federal award activity of Chicot Memorial Medical Center (Medical Center) under programs of the federal government for the year ended March 31, 2022. The information is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance). Because the schedule presents only a selected portion of the operations of the Medical Center, it is not intended to and does not present the financial position, changes in net assets, or cash flows of the Medical Center.
Title: Provider Relief Fund and American Rescue Plan (ARP) Rural Distribution Accounting Policies: Expenditures reported on the schedule are reported on the accrual basis of accounting, with the exception for the COVID19 Claims Reimbursement for the Uninsured Program and the COVID19 Coverage Assistance Fund (Federal Financial Assistance Listing / CFDA #93.461), which is based on when the claim is eligible evidenced by the receipt of monies from the federal agency. When applicable, such expenditures are recognized following the cost principles contained in the Uniform Guidance, wherein certain types of expenditures are not allowable or are limited as to reimbursement. No federal financial assistance has been provided to a subrecipient. De Minimis Rate Used: N Rate Explanation: The Medical Center has not elected to use the 10% de minimis cost rate. The Medical Center received amounts from the U.S. Department of Health and Human Services (HHS) through the Provider Relief Fund (PRF) and American Rescue Plan (ARP) Rural Distribution program (Federal Financial Assistance Listing / CFDA #93.498) during the years ended March 31, 2022 and 2021 totaling $731,344 and $4,039,005. The Medical Center incurred eligible expenditures, including lost revenue, and therefore, recognized revenues totaling $0 and $4,039,005 for the years ended March 31, 2022 and 2021 on the financial statements. As of March 31, 2022, the Medical Center had a refundable advance balance of $731,344. In accordance with the 2021 compliance supplement, the PRF and ARP Rural Distribution expenditures recognized on the scheduleare based on the reporting to HHS for Period 1, defined as payments received during April 10, 2020 to June 30, 2020 of $4,039,005, plus interest earned of $4,911, as required under the PRF and ARP Rural Distribution program.The amount of PRF and ARP Rural Distribution program expenditures included on the schedule requires management to make estimates and assumptions that affect the reported amounts. Accordingly, such expenditures are considered a significant estimate. Estimates and assumptions may include reducing actual expenses by amounts that have been reimbursed or are obligated to be reimbursed by other sources, estimating marginal increases in expenses related to coronavirus and the calculation of lost revenue. Actual results could differ from those estimates.

Finding Details

Department of Health and Human Services Federal Financial Assistance Listing / CFDA #93.498 COVID-19 Provider Relief Fund and American Rescue Plan (ARP) Rural Distribution Applicable Federal Award Number and Year- Period 1 TIN #38-3807713 Reporting Material Weakness in Internal Control Over Compliance and Material Noncompliance Activities Allowed or Unallowed and Allowable Costs/Cost Principles Material Weakness in Internal Control Over Compliance Criteria: 2 CFR 200.303(a) establishes that the auditee must establish and maintain effective internal control over the federal award that provides assurance that the entity is managing the federal award in compliance with federal statutes, regulations, and terms and conditions of the federal award. Condition: The Medical Center tracked patient care revenues internally within a spreadsheet. The revenues included on the spreadsheet and the Period 1 report to HRSA, which were utilized to calculate lost revenues, contained an error. Cause: The Medical Center?s internal control to review and approve accurate patient care revenues, which were utilized to calculate lost revenues, did not identify and correct the errors included in the report submitted to HRSA for Period 1 on a timely manner. Effect: The reporting to HRSA for Period 1 included errors in the reporting of patient care revenue and lost revenues. The result of the errors was an increase in eligible lost revenues available under the program. Questioned Costs: None. While there were errors identified on the Period 1 report to HRSA, the result was an increase in eligible lost revenues under the program. Context: All 10 key line items related to the calculation of lost revenues attributable to coronavirus based on an Option 1 ? 2019 Actuals calculation were tested. The Medical Center did not reflect adjustments required as a result of the audit of the fiscal year 2020 financial statements. The adjustments reduced patient care revenue by $433,089 and potentially impact up to 4 key line items. Ultimately, the impact of correcting patient care revenues for the audit adjustments is expected to increase lost revenues. Repeat Finding from Prior Years: No Recommendation: We recommend the Medical Center modify internal control policies to ensure any errors in the schedule or the report are identified prior to reporting. The patient care revenues reported should include all audit and other adjustments that could have an impact on the calculation of lost revenues. Views of Responsible Officials: Management agrees with the finding.
Department of Health and Human Services Federal Financial Assistance Listing / CFDA #93.498 COVID-19 Provider Relief Fund and American Rescue Plan (ARP) Rural Distribution Applicable Federal Award Number and Year- Period 1 TIN #38-3807713 Reporting Material Weakness in Internal Control Over Compliance and Material Noncompliance Activities Allowed or Unallowed and Allowable Costs/Cost Principles Material Weakness in Internal Control Over Compliance Criteria: 2 CFR 200.303(a) establishes that the auditee must establish and maintain effective internal control over the federal award that provides assurance that the entity is managing the federal award in compliance with federal statutes, regulations, and terms and conditions of the federal award. Condition: The Medical Center tracked eligible expenses internally within a spreadsheet. The spreadsheet included errors in the calculation of allowable expenditures, which were included on the Period 1 report to the Health Resources and Services Administration (HRSA). Cause: The Medical Center?s internal control to review and approve eligible expenditures did not identify and correct the errors included in the report submitted to HRSA for Period 1 on a timely manner. Effect: The reporting to HRSA for Period 1 included errors in the reporting of expenses. The result of the errors was an increase in eligible expenditures under the program. Questioned Costs: None. While there were errors identified on the Period 1 report to HRSA, the result was an increase in eligible expenditures under the program. Context: The Total Other Provider Relief Fund Expenses amount on the Period 1 report to HRSA agreed to an underlying schedule of expenses. A sample of 25 expenditures out of a population of 123 were tested. There were errors in 21 items tested. After updating the calculations to correct the errors identified, the result was an understatement of allowable expenses available to include on the Period 1 report to HRSA. Repeat Finding from Prior Years: No Recommendation: We recommend the Medical Center modify internal control policies to ensure any errors in the schedule or the report are identified prior to reporting. The expenses claimed should be based on accurate calculations and underlying data. Views of Responsible Officials: Management agrees with the finding.
Department of Health and Human Services Federal Financial Assistance Listing / CFDA #93.498 COVID-19 Provider Relief Fund and American Rescue Plan (ARP) Rural Distribution Applicable Federal Award Number and Year- Period 1 TIN #38-3807713 Reporting Material Weakness in Internal Control Over Compliance and Material Noncompliance Activities Allowed or Unallowed and Allowable Costs/Cost Principles Material Weakness in Internal Control Over Compliance Criteria: 2 CFR 200.303(a) establishes that the auditee must establish and maintain effective internal control over the federal award that provides assurance that the entity is managing the federal award in compliance with federal statutes, regulations, and terms and conditions of the federal award. Condition: The Medical Center tracked patient care revenues internally within a spreadsheet. The revenues included on the spreadsheet and the Period 1 report to HRSA, which were utilized to calculate lost revenues, contained an error. Cause: The Medical Center?s internal control to review and approve accurate patient care revenues, which were utilized to calculate lost revenues, did not identify and correct the errors included in the report submitted to HRSA for Period 1 on a timely manner. Effect: The reporting to HRSA for Period 1 included errors in the reporting of patient care revenue and lost revenues. The result of the errors was an increase in eligible lost revenues available under the program. Questioned Costs: None. While there were errors identified on the Period 1 report to HRSA, the result was an increase in eligible lost revenues under the program. Context: All 10 key line items related to the calculation of lost revenues attributable to coronavirus based on an Option 1 ? 2019 Actuals calculation were tested. The Medical Center did not reflect adjustments required as a result of the audit of the fiscal year 2020 financial statements. The adjustments reduced patient care revenue by $433,089 and potentially impact up to 4 key line items. Ultimately, the impact of correcting patient care revenues for the audit adjustments is expected to increase lost revenues. Repeat Finding from Prior Years: No Recommendation: We recommend the Medical Center modify internal control policies to ensure any errors in the schedule or the report are identified prior to reporting. The patient care revenues reported should include all audit and other adjustments that could have an impact on the calculation of lost revenues. Views of Responsible Officials: Management agrees with the finding.
Department of Health and Human Services Federal Financial Assistance Listing / CFDA #93.498 COVID-19 Provider Relief Fund and American Rescue Plan (ARP) Rural Distribution Applicable Federal Award Number and Year- Period 1 TIN #38-3807713 Reporting Material Weakness in Internal Control Over Compliance and Material Noncompliance Activities Allowed or Unallowed and Allowable Costs/Cost Principles Material Weakness in Internal Control Over Compliance Criteria: 2 CFR 200.303(a) establishes that the auditee must establish and maintain effective internal control over the federal award that provides assurance that the entity is managing the federal award in compliance with federal statutes, regulations, and terms and conditions of the federal award. Condition: The Medical Center tracked eligible expenses internally within a spreadsheet. The spreadsheet included errors in the calculation of allowable expenditures, which were included on the Period 1 report to the Health Resources and Services Administration (HRSA). Cause: The Medical Center?s internal control to review and approve eligible expenditures did not identify and correct the errors included in the report submitted to HRSA for Period 1 on a timely manner. Effect: The reporting to HRSA for Period 1 included errors in the reporting of expenses. The result of the errors was an increase in eligible expenditures under the program. Questioned Costs: None. While there were errors identified on the Period 1 report to HRSA, the result was an increase in eligible expenditures under the program. Context: The Total Other Provider Relief Fund Expenses amount on the Period 1 report to HRSA agreed to an underlying schedule of expenses. A sample of 25 expenditures out of a population of 123 were tested. There were errors in 21 items tested. After updating the calculations to correct the errors identified, the result was an understatement of allowable expenses available to include on the Period 1 report to HRSA. Repeat Finding from Prior Years: No Recommendation: We recommend the Medical Center modify internal control policies to ensure any errors in the schedule or the report are identified prior to reporting. The expenses claimed should be based on accurate calculations and underlying data. Views of Responsible Officials: Management agrees with the finding.